Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Schaule, J.
Kroeze, S.G.C.
Blanck, O.
Stera, S.
Kahl, K.H.
Roeder, F.
Combs, S.E.
Kaul, D.
Claes, A.
Schymalla, M.M.
Adebahr, S.
Eckert, F.
Lohaus, F.
Abbasi-Senger, N.
Henke, G.
Szuecs, M.
Geier, M.
Sundahl, N.
Buergy, D.
Dummer, R.
Guckenberger, M.

Open link

Publication date

January 2020

DOI

10.1186/s13014-020-01708-y

Publisher

Springer Science and Business Media LLC

Abstract

An amendment to this paper has been published and can be accessed via the original article

Extracted data

Topics

We use cookies to provide a better user experience.

Data Protection

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Schaule, J.
Kroeze, S.G.C.
Blanck, O.
Stera, S.
Kahl, K.H.
Roeder, F.
Combs, S.E.
Kaul, D.
Claes, A.
Schymalla, M.M.
Adebahr, S.
Eckert, F.
Lohaus, F.
Abbasi-Senger, N.
Henke, G.
Szuecs, M.
Geier, M.
Sundahl, N.
Buergy, D.
Dummer, R.
Guckenberger, M.

Open link

Publication date

January 2020

DOI

10.1186/s13014-020-01708-y

Publisher

Springer Science and Business Media LLC

Abstract

An amendment to this paper has been published and can be accessed via the original article

Extracted data

Topics

van Breeschoten, Jesper
Wouters, Michel W. J. M.
Hilarius, Doranne L.
Haanen, John B.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S.
Suijkerbuijk, Karijn P. M.
Blokx, Willeke A. M.
ten Tije, Bert-Jan J.
van der Veldt, Astrid A. M.
Vreugdenhil, Art
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.

May 2021

Since the publication of this paper, the authors have noticed an error in the Abstract where the val...

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival

Valpione, Sara
Mundra, Piyushkumar A.
Galvani, Elena
Campana, Luca G.
Lorigan, Paul
De Rosa, Francesco
Gupta, Avinash
Weightman, John
Mills, Sarah
Dhomen, Nathalie
Marais, Richard

July 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...

Correction:First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis (Mar, 10.1038/s41416-022-01772-z, 2022)

van Breeschoten, Jesper
Wouters, Michel W. J. M.
Hilarius, Doranne L.
Haanen, John B.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S.
Suijkerbuijk, Karijn P. M.
Blokx, Willeke A. M.
ten Tije, Bert-Jan J.
van der Veldt, Astrid A. M.
Vreugdenhil, Art
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis (Mar, 10.1038/s41416-022-01772-z, 2022)

van Breeschoten, Jesper
Wouters, Michel W. J. M.
Hilarius, Doranne L.
Haanen, John B.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S.
Suijkerbuijk, Karijn P. M.
Blokx, Willeke A. M.
ten Tije, Bert-Jan J.
van der Veldt, Astrid A. M.
Vreugdenhil, Art
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Tije, Bert-Jan J Ten
Veldt, Astrid A M van der
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Tije, Bert-Jan J Ten
Veldt, Astrid A M van der
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Correction: Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: A multivariate analysis of 214 cases. [J Transl Med., 15, (2017) (227)] DOI: 10.1186/s12967-017-1332-3

Pizzichetta, Maria A.
Massi, Daniela
Mandalà, Mario
Queirolo, Paola
Stanganelli, Ignazio
De Giorgi, Vincenzo
Ghigliotti, Giovanni
Cavicchini, Stefano
Quaglino, Pietro
Corradin, Maria T.
Rubegni, Pietro
Alaibac, Mauro
Astorino, Stefano
Ayala, Fabrizio
Magi, Serena
Mazzoni, Laura
Manganoni, Maria Ausilia
Talamini, Renato
Serraino, Diego
Palmieri, Giuseppe

January 2018

In the original version of this article [1], published on 7 November 2017, affiliation 18 has been i...

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival.

Valpione, Sara
Mundra, Piyushkumar A
Galvani, Elena
Campana, Luca G
Lorigan, Paul
De Rosa, Francesco
Gupta, Avinash
Weightman, John
Mills, Sarah
Dhomen, Nathalie
Marais, Richard

August 2021

From Europe PMC via Jisc Publications RouterHistory: ppub 2021-07-01, epub 2021-07-22Publication sta...

van Breeschoten, Jesper
Wouters, Michel W. J. M.
Hilarius, Doranne L.
Haanen, John B.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S.
Suijkerbuijk, Karijn P. M.
Blokx, Willeke A. M.
ten Tije, Bert-Jan J.
van der Veldt, Astrid A. M.
Vreugdenhil, Art
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.

May 2021

Since the publication of this paper, the authors have noticed an error in the Abstract where the val...

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival

Valpione, Sara
Mundra, Piyushkumar A.
Galvani, Elena
Campana, Luca G.
Lorigan, Paul
De Rosa, Francesco
Gupta, Avinash
Weightman, John
Mills, Sarah
Dhomen, Nathalie
Marais, Richard

July 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...

Correction:First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis (Mar, 10.1038/s41416-022-01772-z, 2022)

van Breeschoten, Jesper
Wouters, Michel W. J. M.
Hilarius, Doranne L.
Haanen, John B.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S.
Suijkerbuijk, Karijn P. M.
Blokx, Willeke A. M.
ten Tije, Bert-Jan J.
van der Veldt, Astrid A. M.
Vreugdenhil, Art
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis (Mar, 10.1038/s41416-022-01772-z, 2022)

van Breeschoten, Jesper
Wouters, Michel W. J. M.
Hilarius, Doranne L.
Haanen, John B.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S.
Suijkerbuijk, Karijn P. M.
Blokx, Willeke A. M.
ten Tije, Bert-Jan J.
van der Veldt, Astrid A. M.
Vreugdenhil, Art
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Tije, Bert-Jan J Ten
Veldt, Astrid A M van der
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Tije, Bert-Jan J Ten
Veldt, Astrid A M van der
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2022

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Pizzichetta, Maria A.
Massi, Daniela
Mandalà, Mario
Queirolo, Paola
Stanganelli, Ignazio
De Giorgi, Vincenzo
Ghigliotti, Giovanni
Cavicchini, Stefano
Quaglino, Pietro
Corradin, Maria T.
Rubegni, Pietro
Alaibac, Mauro
Astorino, Stefano
Ayala, Fabrizio
Magi, Serena
Mazzoni, Laura
Manganoni, Maria Ausilia
Talamini, Renato
Serraino, Diego
Palmieri, Giuseppe

January 2018

In the original version of this article [1], published on 7 November 2017, affiliation 18 has been i...

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival.

Valpione, Sara
Mundra, Piyushkumar A
Galvani, Elena
Campana, Luca G
Lorigan, Paul
De Rosa, Francesco
Gupta, Avinash
Weightman, John
Mills, Sarah
Dhomen, Nathalie
Marais, Richard

August 2021

From Europe PMC via Jisc Publications RouterHistory: ppub 2021-07-01, epub 2021-07-22Publication sta...

van Breeschoten, Jesper
Wouters, Michel W. J. M.
Hilarius, Doranne L.
Haanen, John B.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S.
Suijkerbuijk, Karijn P. M.
Blokx, Willeke A. M.
ten Tije, Bert-Jan J.
van der Veldt, Astrid A. M.
Vreugdenhil, Art
Boers-Sonderen, Marye J.
van den Eertwegh, Alfonsus J. M.

May 2021

Since the publication of this paper, the authors have noticed an error in the Abstract where the val...

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival

Valpione, Sara
Mundra, Piyushkumar A.
Galvani, Elena
Campana, Luca G.
Lorigan, Paul
De Rosa, Francesco
Gupta, Avinash
Weightman, John
Mills, Sarah
Dhomen, Nathalie
Marais, Richard

July 2021

From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...

Correction:First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

van Breeschoten, Jesper
Wouters, Michel W J M
Hilarius, Doranne L
Haanen, John B
Blank, Christian U
Aarts, Maureen J B
van den Berkmortel, Franchette W P J
de Groot, Jan-Willem B
Hospers, Geke A P
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Roos S
Suijkerbuijk, Karijn P M
Blokx, Willeke A M
Ten Tije, Bert-Jan J
van der Veldt, Astrid A M
Vreugdenhil, Art
Boers-Sonderen, Marye J
van den Eertwegh, Alfonsus J M

May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1</p

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Abstract

Extracted data

Topics

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Abstract

Extracted data

Topics

Related items

Related items